Takuji Gotoda Selected Research

Takuji Gotoda Research Topics

Disease

31	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2003
20	Neoplasms (Cancer) 01/2023 - 12/2000
14	Infections 01/2023 - 01/2006
7	Hemorrhage 11/2023 - 01/2006
6	Lymphatic Metastasis 01/2022 - 08/2010
5	Esophageal Neoplasms (Esophageal Cancer) 03/2023 - 06/2003
4	Pathologic Constriction (Stenosis) 05/2018 - 07/2008
3	Pain (Aches) 09/2023 - 01/2009
3	Peptic Ulcer (Peptic Ulcers) 04/2021 - 08/2013
2	Constipation 10/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 04/2021 - 03/2016
2	Esophageal Squamous Cell Carcinoma 09/2020 - 06/2016
2	Atrophic Gastritis 01/2019 - 02/2013
2	Exanthema (Rash) 06/2018 - 01/2016
2	Necrosis 02/2015 - 01/2015
2	Hypotension (Low Blood Pressure) 01/2015 - 10/2014
2	Ulcer 08/2013 - 02/2012
2	Polyps 08/2009 - 11/2004
1	Inflammation (Inflammations) 12/2023
1	Halitosis 05/2022
1	Ileus 02/2022
1	Meningeal Carcinomatosis 12/2021
1	Adenocarcinoma 12/2021
1	Body Weight Changes 12/2021
1	Anemia 09/2021
1	Esophagitis 04/2021
1	Fibrosis (Cirrhosis) 04/2021
1	Cough 04/2021
1	Body Weight (Weight, Body) 04/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2021
1	Ulcerative Colitis 01/2021
1	Ascites 01/2021
1	Residual Neoplasm 02/2019
1	Frailty 02/2019
1	Diarrhea 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

5	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2008
3	BariumIBA 01/2024 - 05/2016
3	AnticoagulantsIBA 11/2023 - 02/2009
3	Pepsinogen A (Pepsinogen)IBA 11/2023 - 02/2013
3	Proton Pump InhibitorsIBA 04/2021 - 02/2012
3	Propofol (Diprivan)FDA LinkGeneric 04/2015 - 08/2010
3	MetalsIBA 02/2015 - 01/2015
3	SolutionsIBA 05/2013 - 05/2008
2	AntralIBA 12/2023 - 12/2015
2	Amoxicillin (Wymox)FDA LinkGeneric 12/2021 - 04/2021
2	CytokinesIBA 02/2021 - 01/2017
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2018 - 02/2009
2	Midazolam (Versed)FDA LinkGeneric 04/2015 - 08/2010
2	PlasticsIBA 02/2015 - 01/2015
1	CoagulantsIBA 11/2023
1	Immunoglobulin G (IgG)IBA 11/2023
1	AcidsIBA 01/2023
1	PotassiumIBA 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023
1	SteroidsIBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 05/2022
1	Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric 02/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 12/2021
1	Gemcitabine FDA Link 12/2021
1	130-nm albumin-bound paclitaxelIBA 12/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2021
1	ElectrolytesIBA 10/2021
1	CholesterolIBA 09/2021
1	HDL CholesterolIBA 09/2021
1	B7-H1 AntigenIBA 04/2021
1	NivolumabIBA 04/2021
1	PlatinumIBA 04/2021
1	Immune Checkpoint InhibitorsIBA 04/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2021
1	Coloring Agents (Dyes)IBA 04/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2021
1	Transcription Factors (Transcription Factor)IBA 02/2021
1	GlucocorticoidsIBA 01/2021
1	InterleukinsIBA 01/2021
1	BismuthIBA 04/2019
1	Panitumumab (Vectibix)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	Growth Factor ReceptorsIBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	ubiquinolIBA 01/2019

Therapy/Procedure

26	Therapeutics 01/2023 - 01/2003
11	Gastrectomy 01/2022 - 12/2000
6	Endoscopes 09/2023 - 07/2005
6	Traction 03/2023 - 02/2004
6	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 12/2000
4	Stents 02/2015 - 06/2011
3	Esophagectomy 04/2021 - 10/2010
3	Chemoradiotherapy 09/2020 - 06/2003
3	Drug Therapy (Chemotherapy) 02/2019 - 11/2008
3	Self Expandable Metallic Stents 06/2011 - 06/2003
2	Conservative Treatment 02/2022 - 01/2015
2	Surgical Instruments (Clip) 03/2021 - 01/2021
2	Sclerotherapy 01/2018 - 05/2013
2	Anesthesia 03/2016 - 01/2009
2	Blood Transfusion (Blood Transfusions) 02/2014 - 01/2006
1	Duration of Therapy 01/2023
1	Decompression 02/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2021